Literature DB >> 16538126

Staphylococcus aureus ulcer associated with continuous wear of silicone hydrogel contact lenses.

Muriel M Schornack1, Daniel Peterson.   

Abstract

PURPOSE: To report a case of culture-positive Staphylococcus aureus keratitis associated with continuous wear of lotrafilcon A lenses.
METHODS: The case report of a patient who developed microbial keratitis while wearing lotrafilcon A contact lenses is presented.
RESULTS: A 41-year-old white man had worn polymacon contact lenses successfully for at least 10 years. He habitually replaced the lenses every 1 to 2 years and frequently wore them continuously for up to 3 months. He was refitted with silicone hydrogel lenses and was advised to remove and replace the lenses monthly. Approximately 18 months later, he developed a midperipheral, culture-positive S. aureus ulcer in his right eye. He was treated with fortified cefazolin and gentamicin for 2 weeks, followed by ciprofloxacin for 2 weeks. The ulcer resolved completely. The patient's final visual acuity was 20/20 in the affected eye.
CONCLUSIONS: The increased oxygen permeability of silicone hydrogel contact lens materials may reduce the risk of hypoxic complications of continuous contact lens wear. As this case shows, however, even patients who have continuously worn lenses with very low oxygen permeability without incident can develop microbial keratitis when wearing silicone hydrogel lenses. Contact lens practitioners should inform patients of the potential risks of continuous wear and of factors that may increase those risks.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16538126     DOI: 10.1097/01.icl.0000174754.45463.84

Source DB:  PubMed          Journal:  Eye Contact Lens        ISSN: 1542-2321            Impact factor:   2.018


  1 in total

1.  Staphylococcus aureus protein A induced inflammatory response in human corneal epithelial cells.

Authors:  Ashok Kumar; Alexander Mark Tassopoulos; Qiong Li; Fu-Shin X Yu
Journal:  Biochem Biophys Res Commun       Date:  2007-01-23       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.